Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment) | Bentham Science

Generic placeholder image

Current Radiopharmaceuticals

Author(s): Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

DOI: 10.2174/187447100901151123124826

Download PDF Flyer Cite As

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

Page: [6 - 7] Pages: 2

* (Excluding Mailing and Handling)

Cite As